Sleep apnea treatment may cut heart ablation need in AFib patients

NCT ID NCT04606693

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether screening for and treating sleep apnea can reduce the burden of atrial fibrillation (AFib) in patients who are candidates for heart ablation. Fifty adults with paroxysmal or persistent AFib that hasn't responded to medication will be screened for sleep apnea. Those diagnosed will receive standard treatment (like CPAP or lifestyle changes) and be monitored for three months. The goal is to see if their AFib improves enough to avoid the need for ablation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
CPAP and lifestyle measures for sleep apnea
What this could lead to
If successful, this could show that treating sleep apnea helps control atrial fibrillation, potentially reducing the need for heart ablation in some patients.
What could go wrong
This is a small, non-randomized study with only 50 participants, so results may not apply broadly. It is also early-stage and observational, so it cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APNEA SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Clínico San Carlos

    RECRUITING

    Madrid, Madrid, 28040, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.